Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011-2012 influenza vaccine season

Immunity and Ageing

Volumn 10, Issue 1, 2013, Pages

  Frasca, Daniela ^a   Diaz, Alain ^a   Romero, Maria ^a   Mendez, Nicholas V ^a   Landin, Ana Marie ^a   Blomberg, Bonnie B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; B cells; Influenza vaccine response

Indexed keywords

CYTIDINE DEAMINASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ETHNICITY; FEMALE; GENE EXPRESSION; GROUPS BY AGE; HALF LIFE TIME; HISPANIC; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL MEMORY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MALE; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; RACE; SEROLOGY; T LYMPHOCYTE; TREATMENT RESPONSE;

EID: 84876698358     PISSN: None     EISSN: 17424933     Source Type: Journal    
DOI: 10.1186/1742-4933-10-14     Document Type: Article

References (42)

1. Loerbroks A, Stock C, Bosch JA, Litaker DG, Apfelbacher CJ. Influenza vaccination coverage among high-risk groups in 11 European countries. Eur J Public Health 2012, 22:562-568. 10.1093/eurpub/ckr094, 21750011.
2. Zimmerman RK, Lauderdale DS, Tan SM, Wagener DK. Prevalence of high-risk indications for influenza vaccine varies by age, race, and income. Vaccine 2010, 28:6470-6477. 10.1016/j.vaccine.2010.07.037, 2939262, 20674882.
3. Ferrucci L, Guralnik JM, Pahor M, Corti MC, Havlik RJ. Hospital diagnoses, medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA 1997, 277:728-734. 10.1001/jama.1997.03540330050034, 9042845.
4. Monto AS, Ansaldi F, Aspinall R, McElhaney JE, Montano LF, Nichol KL. Influenza control in the 21st century: Optimizing protection of older adults. Vaccine 2009, 27:5043-5053. 10.1016/j.vaccine.2009.06.032, 19559118.
5. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA. Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP), 2010. MMWR Recomm Rep 2011, 59:1-62.
6. Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24:1159-1169. 10.1016/j.vaccine.2005.08.105, 16213065.
7. McElhaney JE. Influenza vaccine responses in older adults. Ageing Res Rev 2011, 10:379-388. 10.1016/j.arr.2010.10.008, 3061971, 21055484.
8. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007, 7:658-666. 10.1016/S1473-3099(07)70236-0, 17897608.
9. Ahmed AE, Nicholson KG, Nguyen-Van-Tam JS. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet 1995, 346:591-595. 10.1016/S0140-6736(95)91434-X, 7651002.
10. Keitel WA, Cate TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol 1988, 127:353-364.
11. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995, 123:518-527. 10.7326/0003-4819-123-7-199510010-00008, 7661497.
12. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998, 178:53-60. 10.1086/515616, 9652423.
13. Vu T, Farish S, Jenkins M, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002, 20:1831-1836. 10.1016/S0264-410X(02)00041-5, 11906772.
14. Crum-Cianflone NF, Collins G, Defang G, Iverson E, Eberly LE, Duplessis C. Immunoglobulin G subclass levels and antibody responses to the 2009 influenza A (H1N1) monovalent vaccine among human immunodeficiency virus (HIV)-infected and HIV-uninfected adults. Clin Exp Immunol 2012, 168:135-141. 10.1111/j.1365-2249.2011.04550.x, 3390504, 22385248.
15. Chen WH, Cross AS, Edelman R, Sztein MB, Blackwelder WC, Pasetti MF. Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine. Vaccine 2011, 29:2865-2873. 10.1016/j.vaccine.2011.02.017, 3070775, 21352939.
16. El-Madhun AS, Cox RJ, Haaheim LR. The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination. J Infect Dis 1999, 180:1356-1360. 10.1086/315003, 10479172.
17. Garcon NM, Groothuis J, Brown S, Lauer B, Pietrobon P, Six HR. Serum IgG subclass antibody responses in children vaccinated with influenza virus antigens by live attenuated or inactivated vaccines. Antiviral Res 1990, 14:109-116. 10.1016/0166-3542(90)90048-C, 2275526.
18. Hocart MJ, Mackenzie JS, Stewart GA. Serum IgG subclass responses of humans to inactivated and live influenza A vaccines compared to natural infections with influenza A. J Med Virol 1990, 30:92-96. 10.1002/jmv.1890300203, 2313275.
19. Julkunen I, Hovi T, Seppala I, Makela O. Immunoglobulin G subclass antibody responses in influenza A and parainfluenza type 1 virus infections. Clin Exp Immunol 1985, 60:130-138. 1577008, 2988830.
20. Powers DC. Effect of age on serum immunoglobulin G subclass antibody responses to inactivated influenza virus vaccine. J Med Virol 1994, 43:57-61. 10.1002/jmv.1890430111, 8083650.
21. Hammarstrom L, Smith CI. IgG subclass changes in response to vaccination. Monogr Allergy 1986, 19:241-252.
22. Yount WJ, Dorner MM, Kunkel HG, Kabat EA. Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers. J Exp Med 1968, 127:633-646. 10.1084/jem.127.3.633, 2138455, 4169968.
23. Banerjee K, Klasse PJ, Sanders RW, Pereyra F, Michael E, Lu M. IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines. AIDS Res Hum Retroviruses 2010, 26:445-458. 10.1089/aid.2009.0223, 2864049, 20377426.
24. Stepanova L, Naykhin A, Kolmskog C, Jonson G, Barantceva I, Bichurina M. The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly. J Clin Virol 2002, 24:193-201. 10.1016/S1386-6532(01)00246-3, 11856620.
25. DelaRosa O, Pawelec G, Peralbo E, Wikby A, Mariani E, Mocchegiani E. Immunological biomarkers of ageing in man: changes in both innate and adaptive immunity are associated with health and longevity. Biogerontology 2006, 7:471-481. 10.1007/s10522-006-9062-6, 16957868.
26. Effros RB. Genetic alterations in the ageing immune system: impact on infection and cancer. Mech Ageing Dev 2003, 124:71-77. 10.1016/S0047-6374(02)00171-9, 12618008.
27. Franceschi C, Valensin S, Bonafe M, Paolisso G, Yashin AI, Monti D, De Benedictis G. The network and the remodeling theories of aging: historical background and new perspectives. Exp Gerontol 2000, 35:879-896. 10.1016/S0531-5565(00)00172-8, 11053678.
28. Shaw AC, Joshi S, Greenwood H, Panda A, Lord JM. Aging of the innate immune system. Curr Opin Immunol 2010, 22:507-513. 10.1016/j.coi.2010.05.003, 20667703.
29. Okazaki IM, Kinoshita K, Muramatsu M, Yoshikawa K, Honjo T. The AID enzyme induces class switch recombination in fibroblasts. Nature 2002, 416:340-345. 10.1038/nature727, 11875397.
30. Yoshikawa K, Okazaki IM, Eto T, Kinoshita K, Muramatsu M, Nagaoka H, Honjo T. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 2002, 296:2033-2036. 10.1126/science.1071556, 12065838.
31. Pone EJ, Zan H, Zhang J, Al-Qahtani A, Xu Z, Casali P. Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses. Crit Rev Immunol 2010, 30:1-29. 10.1615/CritRevImmunol.v30.i1.10, 3038989, 20370617.
32. Stavnezer J, Guikema JE, Schrader CE. Mechanism and regulation of class switch recombination. Annu Rev Immunol 2008, 26:261-292. 10.1146/annurev.immunol.26.021607.090248, 2707252, 18370922.
33. Muramatsu M, Nagaoka H, Shinkura R, Begum NA, Honjo T. Discovery of activation-induced cytidine deaminase, the engraver of antibody memory. Adv Immunol 2007, 94:1-36.
34. Frasca D, Diaz A, Romero M, Phillips M, Mendez NV, Landin AM, Blomberg BB. Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine. Int Immunol 2012, 24:175-182. 10.1093/intimm/dxr123, 3621378, 22281510.
35. Frasca D, Diaz A, Romero M, Landin AM, Phillips M, Lechner SC. Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans. Vaccine 2010, 28:8077-8084. 10.1016/j.vaccine.2010.10.023, 3223387, 20974306.
36. Powers DC. Summary of a clinical trial with liposome-adjuvanted influenza A virus vaccine in elderly adults. Mech Ageing Dev 1997, 93:179-188. 10.1016/S0047-6374(96)01809-X, 9089582.
37. CDC FluView: A weekly influenza surveillance report prepared by the influenza division 2012, http://www.cdc.gov/flu/weekly/fluactivitysurv.htm, CDC.
38. Frasca D, Landin AM, Lechner SC, Ryan JG, Schwartz R, Riley RL, Blomberg BB. Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol 2008, 180:5283-5290.
39. Khurana S, Frasca D, Blomberg B, Golding H. AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans. PLoS Pathog 2012, 8:e1002920. 10.1371/journal.ppat.1002920, 3441753, 23028320.
40. Ito T, Suzuki Y, Mitnaul L, Vines A, Kida H, Kawaoka Y. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 1997, 227:493-499. 10.1006/viro.1996.8323, 9018149.
41. Murasko DM, Bernstein ED, Gardner EM, Gross P, Munk G, Dran S, Abrutyn E. Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp Gerontol 2002, 37:427-439. 10.1016/S0531-5565(01)00210-8, 11772530.
42. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson NO, Honjo T. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 1999, 274:18470-18476. 10.1074/jbc.274.26.18470, 10373455.